Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly and | Xetra | Healthcare | Pharmaceuticals | €687.65B | 39.4x | 0.42 | €772.20 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Eli Lilly and | Frankfurt | Healthcare | Pharmaceuticals | €687.65B | 39.4x | 0.41 | €762.50 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Johnson Johnson | Frankfurt | Healthcare | Pharmaceuticals | €489.94B | 27.3x | 0.24 | €201.70 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Johnson&Johnson | Xetra | Healthcare | Pharmaceuticals | €489.94B | 27.3x | 0.24 | €201.50 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| AbbVie | Frankfurt | Healthcare | Pharmaceuticals | €312.64B | 88.3x | -71.52 | €177.15 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Roche Holding DRC | Frankfurt | Healthcare | Pharmaceuticals | €284.71B | 19.8x | 0.36 | €43.41 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| AstraZeneca | Frankfurt | Healthcare | Pharmaceuticals | €263.21B | 30.6x | 0.68 | €173.40 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Merck | Frankfurt | Healthcare | Pharmaceuticals | €247.44B | 16.2x | 2 | €99.50 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Merck | Xetra | Healthcare | Pharmaceuticals | €247.44B | 16.2x | 2.03 | €99.45 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| UnitedHealth Group | Frankfurt | Healthcare | Healthcare Providers & Services | €241.98B | 23.8x | -1.62 | €265.40 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Amgen | Frankfurt | Healthcare | Pharmaceuticals | €159.32B | 24.2x | 0.28 | €294 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Amgen | Xetra | Healthcare | Pharmaceuticals | €159.32B | 24.2x | 0.28 | €293.20 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Abbott Laboratories | Frankfurt | Healthcare | Healthcare Equipment & Supplies | €150.63B | 27.4x | -0.53 | €84.56 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Abbott Laboratories | Xetra | Healthcare | Healthcare Equipment & Supplies | €150.63B | 27.4x | -0.52 | €85.76 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Novo Nordisk A S | Xetra | Healthcare | Pharmaceuticals | €149.63B | 11x | 6.08 | €33.88 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Novo Nordisk A S | Frankfurt | Healthcare | Pharmaceuticals | €149.50B | 11x | 6.03 | €34.57 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Gilead Sciences | Xetra | Healthcare | Pharmaceuticals | €147.13B | 20.4x | 0.01 | €117.60 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Gilead Sciences | Frankfurt | Healthcare | Pharmaceuticals | €146.72B | 20.4x | 0.01 | €117.46 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Intuitive Surgical | Frankfurt | Healthcare | Healthcare Equipment & Supplies | €141.21B | 58.5x | 2.6 | €398.55 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Pfizer | Xetra | Healthcare | Pharmaceuticals | €131.55B | 19.9x | -6.01 | €22.93 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Pfizer | Frankfurt | Healthcare | Pharmaceuticals | €131.38B | 19.9x | -5.91 | €22.92 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Danaher | Frankfurt | Healthcare | Healthcare Equipment & Supplies | €119.22B | 39.4x | -8.59 | €168.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Stryker | Frankfurt | Healthcare | Healthcare Equipment & Supplies | €111.12B | 40.4x | 5.07 | €291.60 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Bristol-Myers | Xetra | Healthcare | Pharmaceuticals | €100.02B | 16.6x | 0.09 | €48.85 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Bristol Myers Squibb | Frankfurt | Healthcare | Pharmaceuticals | €99.88B | 16.6x | 0.09 | €48.76 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| GSK plc | Xetra | Healthcare | Pharmaceuticals | €98.29B | 15.2x | 0.12 | €24.49 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| GSK plc | Frankfurt | Healthcare | Pharmaceuticals | €98.29B | 15.2x | 0.12 | €25.03 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Sanofi | Frankfurt | Healthcare | Pharmaceuticals | €98.23B | 20.2x | 0.45 | €81.58 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Sanofi SA | Xetra | Healthcare | Pharmaceuticals | €98.23B | 20.2x | 0.45 | €81.33 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| GSK | Frankfurt | Healthcare | Pharmaceuticals | €97.87B | 15.2x | 0.12 | €48.80 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Vertex | Frankfurt | Healthcare | Pharmaceuticals | €95.59B | 28.9x | 0.03 | €371.25 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Medtronic | Xetra | Healthcare | Healthcare Equipment & Supplies | €95.28B | 24.4x | 2.59 | €73.44 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| EssilorLuxottica | Frankfurt | Healthcare | Healthcare Equipment & Supplies | €95.03B | 41.2x | -13.96 | €205.50 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Medtronic | Frankfurt | Healthcare | Healthcare Equipment & Supplies | €94.58B | 24.5x | 2.59 | €73.64 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| CVS Health Corp | Frankfurt | Healthcare | Healthcare Providers & Services | €81.65B | 54.2x | -0.89 | €65.70 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Chugai Pharma | Frankfurt | Healthcare | Pharmaceuticals | €75.92B | 32.8x | 2.67 | €45.91 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Regeneron Pharma | Frankfurt | Healthcare | Pharmaceuticals | €65.70B | 18.1x | 2.1 | €636.10 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Elevance Health | Frankfurt | Healthcare | Healthcare Providers & Services | €57.70B | 12.3x | -6.64 | €265 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Merck KGaA | Frankfurt | Healthcare | Pharmaceuticals | €51.11B | 19.5x | -3.19 | €117.05 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.9% Upside | Upgrade to Pro+ | |
| Merck | Xetra | Healthcare | Pharmaceuticals | €51.11B | 19.5x | -3.19 | €117.15 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.8% Upside | Upgrade to Pro+ | |
| UCB | Frankfurt | Healthcare | Pharmaceuticals | €50.73B | 32.5x | 0.7 | €269.70 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Takeda Pharma | Frankfurt | Healthcare | Pharmaceuticals | €47.60B | 80.2x | -1.7 | €29.94 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| argenx | Frankfurt | Healthcare | Biotechnology & Medical Research | €44.32B | 40x | 0.73 | €699.20 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Siemens Healthineers | Frankfurt | Healthcare | Healthcare Equipment & Supplies | €42.87B | 21.9x | 2.86 | €38.46 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43.8% Upside | Upgrade to Pro+ | |
| Siemens Healthineers ADR | Frankfurt | Healthcare | Healthcare Equipment & Supplies | €42.87B | 21.9x | 2.87 | €19.70 | 5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Siemens Healthineers | Xetra | Healthcare | Healthcare Equipment & Supplies | €42.78B | 26.4x | 2.86 | €38.34 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43.6% Upside | Upgrade to Pro+ | |
| Bayer | Frankfurt | Healthcare | Pharmaceuticals | €40.10B | -11.1x | 0.26 | €40.90 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.2% Upside | Upgrade to Pro+ | |
| Bayer | Xetra | Healthcare | Pharmaceuticals | €40.10B | -11.1x | 0.26 | €40.74 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.7% Upside | Upgrade to Pro+ | |
| Edwards Lifesciences | Frankfurt | Healthcare | Healthcare Equipment & Supplies | €38.28B | 43.2x | -0.58 | €65.90 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Haleon | Xetra | Healthcare | Pharmaceuticals | €36.18B | 19.7x | 1.07 | €4.09 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |